GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Policy Acquisition Expense

Savara (FRA:YB4P) Policy Acquisition Expense


View and export this data going back to . Start your Free Trial

What is Savara Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Savara Business Description

Industry
Traded in Other Exchanges
Address
1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 19047
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.